NewsRx

Search our medical news database

Duke University Medical Center

Novel apolipoprotein E-derived agent improves outcome after brain trauma

Published in Health Insurance Law Weekly, May 8th, 2005

A novel agent derived from apolipoprotein E (apoE) enhances recovery from brain trauma.

Although APOE4 was "initially identified as a susceptibility gene for the development of Alzheimer disease, the presence of the APOE4 allele is also associated with poor outcome after acute brain injury," neurologists in the United States explained."One mechanism by which apoE may influence neurological outcome is by downregulating the neuroinflammatory response."

"Because it does not readily cross the blood-brain barrier, the apoE holoprotein has limited therapeutic potential," noted J.R. Lynch and colleagues at the Duke University Medical Center....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook